A detailed history of Jennison Associates LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Jennison Associates LLC holds 8,901 shares of TMDX stock, worth $541,358. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,901
Holding current value
$541,358
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$59.28 - $144.9 $527,651 - $1.29 Million
8,901 New
8,901 $554,000
Q2 2023

Aug 03, 2023

SELL
$66.23 - $88.73 $3,443 - $4,613
-52 Reduced 1.21%
4,236 $355,000
Q1 2023

Apr 26, 2023

BUY
$53.63 - $82.33 $229,965 - $353,031
4,288 New
4,288 $324,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $1.94B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Jennison Associates LLC Portfolio

Follow Jennison Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.